SnapShot: Cancer Immunotherapy with Oncolytic Viruses

Cell64.50
Volume: 176, Issue: 5, Pages: 1240
Published: Feb 21, 2019
Abstract
Oncolytic viruses (OVs) preferentially infect and kill cancer cells without harming normal cells. OVs can revert cancer-associated immune suppression and initiate clinically meaningful antitumor immune responses. OVs and their resultant immunological events can act at both primary and metastatic sites. Thus, OVs can be exploited for cancer gene therapies and immunotherapies alone or in combination with other interventions, including immune...
Paper Details
Title
SnapShot: Cancer Immunotherapy with Oncolytic Viruses
Published Date
Feb 21, 2019
Journal
Volume
176
Issue
5
Pages
1240
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.